ES2064533T3 - Acido(1,2,3,4-tetrahidro-9-acridinimino)-ciclohexanocarboxilico y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos. - Google Patents

Acido(1,2,3,4-tetrahidro-9-acridinimino)-ciclohexanocarboxilico y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.

Info

Publication number
ES2064533T3
ES2064533T3 ES90111814T ES90111814T ES2064533T3 ES 2064533 T3 ES2064533 T3 ES 2064533T3 ES 90111814 T ES90111814 T ES 90111814T ES 90111814 T ES90111814 T ES 90111814T ES 2064533 T3 ES2064533 T3 ES 2064533T3
Authority
ES
Spain
Prior art keywords
cyclohexanocarboxilico
acridinimino
tetrahydro
medicines
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90111814T
Other languages
English (en)
Inventor
Lawrence Leo Martin
Joseph Francis Payack
Helen Hu Ong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2064533T3 publication Critical patent/ES2064533T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE PRESENTAN LOS COMPUESTOS DE LA FORMULA (I) EN DONDE X ES HIDROGENO, ALQUIL INFERIOR, ALCOXIDO INFERIOR O HALOGENO; R CUANDO ESTA PRESENTE ES HIDROGENO, ALQUIL INFERIOR O ALQUIL INFERIOR DE ARIL; R1 ES HIDROGENO, ALQUIL INFERIOR O ALQUIL INFERIOR DE ARIL; Y R2 CUANDO ESTA PRESENTE ES HIDROGENO O ALQUIL INFERIOR. DICHOS COMPUESTOS SON UTILES PARA ALIVIAR VARIOS DISFUNCIONES DE MEMORIA CARACTERIZADAS POR UNA DISMINUCION DE LA FUNCION COLINERGICA, TALES COMO LA ENFERMEDAD DE ALZHEIMER.
ES90111814T 1989-06-26 1990-06-22 Acido(1,2,3,4-tetrahidro-9-acridinimino)-ciclohexanocarboxilico y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos. Expired - Lifetime ES2064533T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/371,228 US4999358A (en) 1989-06-26 1989-06-26 (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds

Publications (1)

Publication Number Publication Date
ES2064533T3 true ES2064533T3 (es) 1995-02-01

Family

ID=23463058

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90111814T Expired - Lifetime ES2064533T3 (es) 1989-06-26 1990-06-22 Acido(1,2,3,4-tetrahidro-9-acridinimino)-ciclohexanocarboxilico y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.

Country Status (17)

Country Link
US (1) US4999358A (es)
EP (1) EP0405342B1 (es)
JP (1) JP2600013B2 (es)
KR (1) KR0163186B1 (es)
AT (1) ATE115133T1 (es)
AU (1) AU625221B2 (es)
CA (1) CA2019717C (es)
DE (1) DE69014730T2 (es)
DK (1) DK0405342T3 (es)
ES (1) ES2064533T3 (es)
FI (1) FI96307C (es)
IE (1) IE65462B1 (es)
IL (3) IL94854A (es)
NO (1) NO177053C (es)
NZ (1) NZ234199A (es)
PT (1) PT94472B (es)
ZA (1) ZA904914B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640508B1 (fr) * 1988-12-19 1994-07-01 Dietlin Francois Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire
US5149813A (en) * 1989-06-26 1992-09-22 Hoechst-Roussel Pharmaceuticals Incorporated Process for (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds
US6100276A (en) * 1996-04-12 2000-08-08 Aventis Pharmaceuticals Inc. Isatin derivatives as acetylcholinesterase inhibitors and analgesics
US5968517A (en) * 1996-05-23 1999-10-19 Duncan; Kelvin Winston Process for extraction of proanthocyanidins from botanical material
CN1535682A (zh) 1998-09-30 2004-10-13 ����ҩƷ��ҵ��ʽ���� 改善膀胱排泄能力的药物
US8328939B2 (en) * 2004-05-12 2012-12-11 Applied Materials, Inc. Diffuser plate with slit valve compensation
WO2012154879A2 (en) * 2011-05-09 2012-11-15 Van Andel Research Institute Autophagy inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB595603A (en) * 1944-08-21 1947-12-10 Ward Blenkinsop & Co Ltd Process for the production of arylamino acridine derivatives
DK569087A (da) * 1986-10-31 1988-05-01 Sumitomo Pharma Quinolin-derivater, deres fremstilling og anvendelse
US4851536A (en) * 1987-05-07 1989-07-25 American Home Products Corporation Cyclohexylquinolines as inhibitors of interleukin 1
EP0306826A1 (en) * 1987-09-08 1989-03-15 Hoechst-Roussel Pharmaceuticals Incorporated N-(substituted alkylidene)fused bicycloalkylidene and hetero-alkylidene quinolinamines, a process for their preparation and their use as medicaments
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives

Also Published As

Publication number Publication date
CA2019717A1 (en) 1990-12-26
ATE115133T1 (de) 1994-12-15
IE902290A1 (en) 1991-01-16
IE902290L (en) 1990-12-26
DE69014730D1 (de) 1995-01-19
IL94854A (en) 1994-08-26
EP0405342A1 (en) 1991-01-02
FI96307B (fi) 1996-02-29
ZA904914B (en) 1992-02-26
IL107001A (en) 1994-10-21
FI903181A0 (fi) 1990-06-25
KR910000652A (ko) 1991-01-29
JP2600013B2 (ja) 1997-04-16
NO177053C (no) 1995-07-12
EP0405342B1 (en) 1994-12-07
DE69014730T2 (de) 1995-05-11
KR0163186B1 (ko) 1998-12-01
IL94854A0 (en) 1991-04-15
NO902813L (no) 1990-12-27
NZ234199A (en) 1992-05-26
US4999358A (en) 1991-03-12
AU625221B2 (en) 1992-07-02
CA2019717C (en) 2001-01-23
IL107001A0 (en) 1993-12-28
PT94472B (pt) 1997-05-28
JPH0395161A (ja) 1991-04-19
FI96307C (fi) 1996-06-10
DK0405342T3 (da) 1995-05-15
NO177053B (no) 1995-04-03
NO902813D0 (no) 1990-06-25
IE65462B1 (en) 1995-11-01
AU5775390A (en) 1991-01-03
PT94472A (pt) 1991-02-08

Similar Documents

Publication Publication Date Title
ES2029812T3 (es) Un procedimiento para preparar alfa-alquil-4-amino-3-quinolina-metanoles y 1-(4-aralquilamino-3-quinolil)alcanonas.
ES2064533T3 (es) Acido(1,2,3,4-tetrahidro-9-acridinimino)-ciclohexanocarboxilico y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
ES2051723T3 (es) Procedimiento para preparar tetrahidroaminoquinolinoles heterociclicos condensados.
ES2072334T3 (es) Derivados de 4,5,5a,6-tetrahidro-3h-isoxazolo(5,4,3-kl)acridinas, un procedimiento para su preparacion y su uso como medicamentos.
MX25922A (es) Pirido (3,4-b) pirrolo (1,2-e)(1,4,5)oxadiazepinasy compuestos analogos relacionados un procedimiento para su preparacion y su uso como medicamentos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 405342

Country of ref document: ES